Skip to Main Content

GRI Bio, Inc. Common Stock

GRI Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
GRI Income Statement
GRI Balance Sheet
GRI Cash Flow

Recent trades of GRI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GRI Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GRI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GRI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by GRI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Prevention and treatment of inflammatory conditions May. 30, 2023
  • Patent Title: Hydroxy-substituted amino and ammonium derivatives and their medical use Jan. 31, 2023
  • Patent Title: Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Sep. 27, 2022
  • Patent Title: Hydroxy-substituted amino and ammonium derivatives and their medical use Mar. 23, 2021
  • Patent Title: Prevention and treatment of inflammatory conditions Feb. 23, 2021
  • Patent Title: Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Nov. 10, 2020
  • Patent Title: Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Oct. 27, 2020
  • Patent Title: Hydroxy-substituted amino and ammonium derivatives and their medical use Dec. 04, 2018
  • Patent Title: Prevention and treatment of inflammatory conditions Apr. 24, 2018
  • Patent Title: Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Dec. 26, 2017
  • Patent Title: Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Sep. 05, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GRI in WallStreetBets Daily Discussion

GRI News

Recent insights relating to GRI

CNBC Recommendations

Recent picks made for GRI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRI

GRI Top Shareholders
Shareholder
Shares Held
GRI Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GRI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GRI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top